West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 258,900 | 261,000 | 242,400 | 244,900 | 256,200 |
| Cost of Goods | 187,200 | 182,300 | 173,100 | 175,400 | 190,200 |
| Gross Profit | 71,700 | 78,700 | 69,300 | 69,500 | 66,000 |
| Operating Expenses | 46,000 | 50,300 | 48,200 | 44,400 | 48,300 |
| Operating Income | 25,900 | 28,700 | 21,200 | 25,500 | 17,900 |
| Interest Expense | 3,800 | 3,500 | 3,900 | 3,400 | 4,300 |
| Other Income | 1,100 | 600 | 600 | -700 | 700 |
| Pre-tax Income | 23,200 | 25,800 | 17,900 | 21,400 | 14,300 |
| Income Tax | 6,000 | 6,100 | 2,500 | 3,600 | 800 |
| Net Income Continuous | 17,200 | 19,700 | 15,400 | 17,800 | 13,500 |
| Minority Interests | N/A | N/A | N/A | 0 | 200 |
| Net Income | $17,200 | $19,700 | $15,400 | $17,800 | $13,300 |
| EPS Basic Total Ops | 0.26 | 0.30 | 0.24 | 0.27 | 0.21 |
| EPS Basic Continuous Ops | 0.26 | 0.30 | 0.24 | 0.27 | 0.21 |
| EPS Diluted Total Ops | 0.25 | 0.29 | 0.23 | 0.26 | 0.20 |
| EPS Diluted Continuous Ops | 0.24 | 0.27 | 0.21 | 0.25 | 0.19 |
| EBITDA(a) | $44,200 | $45,200 | $36,200 | $40,700 | $33,400 |